section name header
Index
Acarbose in the Prevention of Cardiovascular Disease and Hypertension in Patients with Impaired Glucose Tolerance
Acute Coronary Syndrome and Myocardial Infarction - Related Resources
Aldosterone Receptor Antagonists Spironolactone and Eplerenone for Congestive Heart Failure
Antioxidants in the Prevention of Cardiovascular Disease
Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke
Antithrombotic Agents in Primary Health Care - Related Resources
Aspirin Dose for the Prevention of Cardiovascular Disease
Aspirin Resistance and Risk of Cardiovascular Morbidity
Beta-Blockers Against other Antihypertensive Drugs
Beta-Blockers for Hypertension
Blood Pressure Targets for People with Hypertension and Cardiovascular Disease
Cardiology
Cardioselective Beta-Blockers for Chronic Obstructive Pulmonary Disease
Cardiovascular diseases
Chelation Therapy for Atherosclerotic Cardiovascular Disease
Choice of Antihypertensive Drug in the Diabetic Patient from Prognostic Point of View
Clinical pharmacology
Clopidogrel Plus Aspirin Versus Aspirin Alone for Preventing Cardiovascular Disease in Acute Non-ST Segment Coronary Syndromes
Clopidogrel Plus Aspirin Vs Aspirin Alone for Preventing Cardiovascular Events
Cochrane review
Colchicine for Pericarditis
Combined Aspirin-Oral Anticoagulant Therapy Compared with Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease
Coronary Heart Disease - Related Resources
Diabetic Nephropathy - Related Resources
Dietary Sodium Restriction, Blood Pressure and Cardiovascular Morbidity
Different Antihypertensive Agents as First Line Therapies
Effect of Dietary Interventions on Diet and Cardiovascular Risk Factors
Effect of Oral Potassium on Blood Pressure
Endocrinology
Estrogen Plus Progestin for Primary Prevention in Healthy Postmenopausal Women
Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Evidence summary
Ezetimibe for the Prevention of Cardiovascular Disease
Female
Fibrates for Primary Prevention of Cardiovascular Disease
Fixed-Dose Combination Therapy for the Prevention of Atherosclerotic Cardiovascular Diseases
Glucagon-Like Peptide Analogues (GLP-1 Analogues) for Type 2 Diabetes
Green and Black Tea for the Primary Prevention of Cardiovascular Disease
Home Blood Pressure (Bp) Measurement Compared to Office Bp
Homocysteine Lowering Interventions for Preventing Cardiovascular Events
Hormone Therapy for Preventing Cardiovascular Disease in Post-Menopausal Women
How Well Do Measures of Bone Mineral Density Predict Occurrence of Osteoporotic Fractures
Hypertension: Diagnosis, Initial Investigations and Starting Treatment - Related Resources
Increased Consumption of Fruit and Vegetables for the Primary Prevention of Cardiovascular Diseases
Infectious diseases
Influenza Vaccines for Preventing Cardiovascular Disease
Internal medicine
Interventions for Reversing Metabolic Syndrome
Ischaemic Stroke and Myocardial Infarction Risk with Combined Oral Contraceptives
Lipid Lowering Therapies in Renal Disease
Lipid Profile as a Marker of Cardiovascular Disease Risk
Long Term Hormone Therapy for Perimenopausal and Postmenopausal Women for Chronic Conditions
Losartan Versus Atenolol for Diabetic Hypertensive Patients with LVH
Low Cardiorespiratory Fitness and Obesity as Risk Factors for Cardiovascular Diseases
Low-Dose Aspirin for Prevention of Vascular Events in Type 2 Diabetes
Lower Limb Ischaemia - Related Resources
Low Glycaemic Index Diets for Cardiovascular Disease
Maternal Health Advantages of Breastfeeding
Mediterranean-Style Diet for the Primary and Secondary Prevention of Cardiovascular Disease
Menopausal Hormone Therapy and Breast Cancer
Migraine - Related Resources
Nsaids and Blood Pressure
Nsaids and Risk of Acute Myocardial Infarction
Nsaids and Risk of Acute Renal Failure
Nutritional medicine
Omega-3 Fatty Acids for Prevention of Cardiovascular Disease
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
Pcsk9 Inhibitors for Prevention of Cardiovascular Disease
Pharmacology
Pharmacotherapy for Mild Hypertension
Plasma Homocysteine Level as a Risk Factor for Major Coronary Events
Platelet Glycoprotein Iib/Iiia Receptor Antagonists in Cardiovascular Disease
Prevention of Myocardial Infarction and Death by Antidyslipidemic Therapy
Prevention of Type 2 Diabetes by Life-Style Changes
Radiotherapy
Reduced Saturated Fat for Preventing Cardiovascular Disease
Reducing Cardiovascular Events by Multifactorial Intervention in Patients with Type 2 Diabetes
Reduction of Cardiovascular Risk after Stopping Smoking
Rheumatoid Arthritis - Related Resources
Risk of Ischaemic Stroke in People with Migraine with Aura
Risk of Morbidity and Mortality from Cardiovascular Disease Following Radiotherapy for Childhood Cancer
Risk of Myocardial Infarction in Users of Third Generation Oral Contraceptives
Selenium Supplementation for the Primary Prevention of Cardiovascular Disease
Sglt-2 Inhibitors and GLP-1 Agonists for Diabetes and Chronic Kidney Disease
Sglt-2 Inhibitors in Type 2 Diabetes
Statins for Improving Renal Outcomes
Statins for Primary Prevention of Venous Thromboembolism
Statins for the Primary Prevention of Cardiovascular Disease
Statin Treatment and Risk of Coronary Heart Disease
Surgery for Morbid Obesity
Systematic review
The Use of Glitazones (Thiazolidinediones) in Heart Failure
Third Generation Oral Contraceptives and Risk of Venous Thromboembolism
Transfusion Thresholds for Guiding Allogeneic Red Blood Cell Transfusion
Treatment and Follow-Up in Type 2 Diabetes - Related Resources
Treatment of Dyslipidaemias - Related Resources
Treatment of Hypertension JNC 7
Vaccinations - Related Resources
Verapamil in Patients with Cardiovascular Disease
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
Yoga for Cardiovascular Disease Prevention